Cerebrospinal fluid biomarkers for depression

keem-ibarra-8jBWlKuASCg-unsplash

In her debut blog, Éimear Foley reviews a recent meta-analysis that identifies possible differences between people experiencing depression and healthy controls.

[read the full story...]

Remote measurement technologies for depression in young people: scalable solution or overplayed potential? #ActiveIngredientsMH

Young African American man pointing his  smartphone screen - Black teenager people

In her debut blog, Annabel Walsh summarises her #ActiveIngredientsMH project which explored the use of remote measurement technologies for depression in children and young people.

[read the full story...]

“Nobody knows the trouble I’ve seen”. Depression and bipolar disorder in people with intellectual disabilities

woman

Kathryn Mitchell and Stephen Moore summarise a recent prospective cohort study in the British Journal of Psychiatry, which looks at the incidence of unipolar and bipolar depression, and mania in adults with intellectual disabilities.

[read the full story...]

Antidepressants for depression: new BAP guidance

shutterstock_103021367

Helge Hasselmann summarises the recently published evidence-based guidance on antidepressants for depression published by the British Association for Psychopharmacology.

[read the full story...]

Health effects of depression: keeping economists’ models on track

shutterstock_169007078

Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.

[read the full story...]